Preclinical studies with FcgammaR bispecific antibodies and granulocyte colony-stimulating factor-primed neutrophils as effector cells against HER-2/neu overexpressing breast cancer

B. Stockmeyer, T. Valerius, R. Repp, I.A.F.M. Heijnen, H.J. Buhring, Y.M. Deo, J.R. Kalden, M. Gramatzki, J.G.J. van de Winkel

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)696-701
Number of pages6
JournalCancer Research
Volume57
Publication statusPublished - 1997

Cite this